Wegovy and Ozempic are medications in the class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1s). They are both manufactured by Novo Nordisk and contain the active compound called semaglutide.
Originally developed as a diabetes medication in 2017, semaglutide was first sold under the brand name Ozempic. In 2021, the manufacturer introduced Wegovy, which contains a higher dose of semaglutide.
The main differences between the two medications are that Wegovy contains a higher dose of semaglutide and was developed specifically for the treatment of overweight and obesity, while Ozempic was originally indicated for the treatment of type 2 diabetes.
Ozempic is FDA-approved for the treatment of type 2 diabetes and obesity in people with type 2 diabetes, while Wegovy is FDA-approved for the treatment of obesity in non-diabetics.
It’s important to note that as of April 2023, Ozempic is still pending FDA approval for non-diabetic weight loss patients. However, the FDA has approved Wegovy as a weight loss treatment for people ages 12 and up who don’t have diabetes.
For obesity, GLP-1 medications are generally prescribed for people with a body mass index (BMI) of 30 or greater or in people with a BMI of 27 or greater who also have a metabolic health condition, like type 2 diabetes or hypertension.
Manage weight loss online
See if you’re a good fit for K Health’s online medical weight loss program.
Wegovy vs. Ozempic: What’s the Difference?
Wegovy and Ozempic contain the same active compound: semaglutide. They are also both injectable medications delivered once weekly.
However, Wegovy is available in higher doses than semaglutide. And since Wegovy recently received FDA approval in 2021, it’s the first weight loss medication to gain approval since 2014.
Here’s a summary of the main differences and similarities between the two medications:
Medication class | Active compound | Drug administration | Starting dose | Highest dose available | Gained FDA approval | |
Wegovy | GLP-1 | Semaglutide | Injection | 0.25 mg/week | 2.4 mg/week | 2021 |
Ozempic | GLP-1 | Semaglutide | Injection | 0.25 mg/week | 2.0 mg/week | 2017 |
Wegovy
Wegovy is the first medication to receive FDA approval for the treatment of chronic weight management since 2014.
Below is some important information about the medication to review before speaking with your healthcare provider about whether or not the medication may be right for you.
Dosage
Because Wegovy is available in higher doses of semaglutide, it enables better crossing of the blood-brain barrier, which can help to increase total weight loss. Still, if prescribed the medication, your healthcare provider will start you on a low dose of Wegovy and gradually increase the dose over 16-20 weeks.
The starting dose of Wegovy is 0.25 mg per week. The highest dose available of the medication is 2.4 mg per week. Gradually increasing the dose can help to reduce the risk of side effects.
Side effects
Gastrointestinal side effects are the most common when taking Wegovy. These include:
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Constipation
- Heartburn
- Burping
Serious side effects are rare, but still possible. If you experience any of the following, please seek emergency treatment:
- Ongoing pain that begins in the upper left or middle of the stomach but may spread to the back, with or without vomiting
- Rash or itching
- Swelling of the eyes, face, mouth, tongue, or throat
- Difficulty breathing or swallowing
- Decreased urination
- Swelling of legs, ankles, or feet
- Vision changes
- Fainting or dizziness
- Pain in upper stomach
- Yellowing of skin or eyes
- Fever
- Clay-colored stools
- Rapid heartbeat
Effectiveness
As a class of medication, GLP-1 medications have been researched for over 16 years and have shown consistent results in the reduction of body weight in obese patients with and without diabetes.
In its announcement of approval, the FDA cited the following results on the effectiveness of Wegovy for the treatment of chronic weight management:
- In one trial, people who received Wegovy lost an average of 12.4% of their initial body weight (the average BMI of the participants was 38)
- In another trial, people who received Wegovy lost 6.2% of their initial body weight when compared to those who only received a placebo
Research also suggests that, in addition to improving metabolic health and body weight, semaglutide may also help to lower the rate of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke in patients with type 2 diabetes at high risk of cardiovascular disease.
Interactions and warnings
Wegovy may not be right for everyone.
People with a personal or family history of medullary thyroid cancer (a rare and primarily genetic type of thyroid cancer) may be at risk of thyroid C-cell tumors. Additionally, people with a rare condition called multiple endocrine neoplasia syndrome type 2 (MEN 2) should not use it.
Tell your provider about any other prescription or over-the-counter (OTC) medications you’re currently taking. Importantly, Wegovy should not be combined with any other GLP-1 or weight loss drug.
Cost
The cost can vary depending on several factors, including your insurance coverage and the rates at your local pharmacy.
Without insurance, Wegovy can cost over $1,500 per month. With coverage, you may pay as little as $25 per month.
Ozempic
Ozempic can be used alongside a diet and exercise program to help control blood sugar levels in adults with type 2 diabetes. It can also be used to reduce the risk of stroke, heart attack, or death in adults with type 2 diabetes and heart and blood vessel disease.
It can also be used for chronic weight management in patients with type 2 diabetes.
Dosage
Ozempic and Wegovy contain the same active compound, but Ozempic is available in slightly lower doses than Wegovy. Like Wegovy, your provider will start you on a low dose of Ozempic: 0.25 mg per week. If recommended by your provider, you may increase your dose of Ozempic by 0.25 mg every four weeks.
The maximum dose of Ozempic is 2.0 mg per week, if recommended by your provider.
Side effects
Possible side effects of Ozempic are the same as the possible side effects of Wegovy, since they contain the same active compound:
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Constipation
- Heartburn
- Burping
As with Wegovy, severe side effects are possible and should be taken seriously. If you experience any of the below symptoms, seek immediate medical attention:
- Ongoing pain that begins in the upper left or middle of the stomach but may spread to the back, with or without vomiting
- Rash or itching
- Swelling of the eyes, face, mouth, tongue, or throat
- Difficulty breathing or swallowing
- Decreased urination
- Swelling of legs, ankles, or feet
- Vision changes
- Fainting or dizziness
- Pain in upper stomach
- Yellowing of skin or eyes
- Fever
- Clay-colored stools
- Rapid heartbeat
Manage weight loss online
See if you’re a good fit for K Health’s online medical weight loss program.
Effectiveness
Like Wegovy, Ozempic has been shown to be effective to help support weight loss as an adjunct therapy to diet and exercise.
Ozempic has also been shown to be an effective treatment for the management of type 2 diabetes.
Interactions and warnings
Like Wegovy, Ozempic should not be used by individuals with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN 2).
As with any medication, it’s important to tell your healthcare provider about any medications, supplements, or vitamins you’re currently taking.
Ozempic should not be combined with any other GLP-1 or weight loss drug.
Cost
The price of Ozempic will vary depending on several factors, including whether or not your insurance covers the cost of the medication.
If not, you could pay $800 or more per monthly supply of the medication. With coverage, you could pay as little as $25.
Is Wegovy or Ozempic Better for Weight Loss?
Both Wegovy and Ozempic can help to support sustained weight loss in overweight and obese individuals who are committed to implementing long-term behavioral modifications including changes in diet, exercise, and stress management.
The higher doses available with Wegovy may help some people to lose more weight, but what works best for one person may not be the same as what works best for you.
Ultimately, neither Wegovy nor Ozempic are intended to be a “quick-fix” for weight loss.
To effectively and safely reap the benefits of either medication, you need to follow your healthcare provider’s recommendations to ensure that you’re consistently incorporating lifestyle modifications while on one of these medications.
How to Get Wegovy or Ozempic
If you’re eligible, you can get Wegovy or Ozempic online through K Health.
Frequently Asked Questions
K Health has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations. We avoid using tertiary references.
-
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. (2022.)
https://pubmed.ncbi.nlm.nih.gov/35015037/ -
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. (2021.)
https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014 -
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes. (2022.)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736331/ -
Semaglutide Injection. (2021.)
https://medlineplus.gov/druginfo/meds/a618008.html -
Semaglutide Shines as Weight Loss Therapy. (2021.)
https://www.medpagetoday.com/primarycare/obesity/91146 -
Updates About Wegovy. (2022.)
https://www.novonordisk-us.com/products/product-supply-update.html -
Wegovy (semaglutide): a new weight loss drug for chronic weight management. (2022.)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717485/